Table 3.
Population demographics.
| Mild | Moderate–severe | Study population | |
|---|---|---|---|
| n = 35 | n = 52 | ||
| Mean age (years) | 68.1 | 69.6 | 69.0 |
| SD 9.4 | SD 9.7 | SD 9.6 | |
| 40–65 years (n) | 12 (34%) | 13 (25%) | 25 (29%) |
| 65+ years (n) | 23 (66%) | 39 (75%) | 62 (71%) |
| Gender | |||
| Female (n) | 13 (37%) | 23 (44%) | 36 (42%) |
| Male (n) | 22 (63%) | 29 (56%) | 51 (58%) |
| Mini mental state examination (mean) | 28.7 | 26.7 | 27.5 |
| SD 1.9 | SD 4.0 | SD 3.4 | |
| Disease duration (years) | 2.7 | 8.2 | 6.0 |
| SD 3.1 | SD 5.4 | SD 5.3 | |
| Disease severity (HY stage) | 35 (40.2%) | 52 (59.8%) | 87 (100%) |
| Stage 1 | 22 (25.3%) | 0 | 22 (25.3%) |
| Stage 1.5 | 2 (2.3%) | 0 | 2 (2.3%) |
| Stage 2 | 11 (12.6%) | 0 | 11 (12.6%) |
| Stage 2.5 | 0 | 26 (29.9%) | 26 (29.9%) |
| Stage 3 | 0 | 16 (18.4%) | 16 (18.4%) |
| Stage 4 | 0 | 10 (11.5%) | 10 (11.5%) |